107 related articles for article (PubMed ID: 26940742)
1. Pyrithione Zn selectively inhibits hypoxia-inducible factor prolyl hydroxylase PHD3.
Na YR; Woo DJ; Kim SY; Yang EG
Biochem Biophys Res Commun; 2016 Apr; 472(2):313-8. PubMed ID: 26940742
[TBL] [Abstract][Full Text] [Related]
2. Selective inhibition of the hypoxia-inducible factor prolyl hydroxylase PHD3 by Zn(II).
Na YR; Woo DJ; Choo H; Chung HS; Yang EG
Chem Commun (Camb); 2015 Jul; 51(53):10730-3. PubMed ID: 26051901
[TBL] [Abstract][Full Text] [Related]
3. Prolyl-hydroxylase PHD3 interacts with pyruvate dehydrogenase (PDH)-E1β and regulates the cellular PDH activity.
Kikuchi D; Minamishima YA; Nakayama K
Biochem Biophys Res Commun; 2014 Aug; 451(2):288-94. PubMed ID: 25088999
[TBL] [Abstract][Full Text] [Related]
4. The stabilization of hypoxia inducible factor modulates differentiation status and inhibits the proliferation of mouse embryonic stem cells.
Binó L; Kučera J; Štefková K; Švihálková Šindlerová L; Lánová M; Kudová J; Kubala L; Pacherník J
Chem Biol Interact; 2016 Jan; 244():204-14. PubMed ID: 26723917
[TBL] [Abstract][Full Text] [Related]
5. Application of in-vitro screening methods on hypoxia inducible factor prolyl hydroxylase inhibitors.
Wu Y; Jiang Z; You Q; Zhang X
Bioorg Med Chem; 2017 Aug; 25(15):3891-3899. PubMed ID: 28625716
[TBL] [Abstract][Full Text] [Related]
6. [(4-Hydroxyl-benzo[4,5]thieno[3,2-c]pyridine-3-carbonyl)-amino]-acetic acid derivatives; HIF prolyl 4-hydroxylase inhibitors as oral erythropoietin secretagogues.
Hong YR; Kim HT; Lee SC; Ro S; Cho JM; Kim IS; Jung YH
Bioorg Med Chem Lett; 2013 Nov; 23(21):5953-7. PubMed ID: 24042008
[TBL] [Abstract][Full Text] [Related]
7. Discovery of neuroprotective agents that inhibit human prolyl hydroxylase PHD2.
Richardson NL; O'Malley LJ; Weissberger D; Tumber A; Schofield CJ; Griffith R; Jones NM; Hunter L
Bioorg Med Chem; 2021 May; 38():116115. PubMed ID: 33862469
[TBL] [Abstract][Full Text] [Related]
8. Effect of proline analogues on activity of human prolyl hydroxylase and the regulation of HIF signal transduction pathway.
Ma X; Wang X; Cao J; Geng Z; Wang Z
PLoS One; 2014; 9(4):e95692. PubMed ID: 24755992
[TBL] [Abstract][Full Text] [Related]
9. Novel complex crystal structure of prolyl hydroxylase domain-containing protein 2 (PHD2): 2,8-Diazaspiro[4.5]decan-1-ones as potent, orally bioavailable PHD2 inhibitors.
Deng G; Zhao B; Ma Y; Xu Q; Wang H; Yang L; Zhang Q; Guo TB; Zhang W; Jiao Y; Cai X; Zhang J; Liu H; Guan X; Lu H; Xiang J; Elliott JD; Lin X; Ren F
Bioorg Med Chem; 2013 Nov; 21(21):6349-58. PubMed ID: 24055079
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel 2-[2-(3-hydroxy-pyridin-2-yl)-thiazol-4-yl]-acetamide derivatives as HIF prolyl 4-hydroxylase inhibitors; SAR, synthesis and modeling evaluation.
Hong YR; Kim HT; Ro S; Cho JM; Lee SH; Kim IS; Jung YH
Bioorg Med Chem Lett; 2014 Jul; 24(14):3142-5. PubMed ID: 24894560
[TBL] [Abstract][Full Text] [Related]
11. HIF-prolyl hydroxylase 2 inhibition enhances the efficiency of mesenchymal stem cell-based therapies for the treatment of critical limb ischemia.
HoWangYin KY; Loinard C; Bakker W; Guérin CL; Vilar J; d'Audigier C; Mauge L; Bruneval P; Emmerich J; Lévy BI; Pouysségur J; Smadja DM; Silvestre JS
Stem Cells; 2014 Jan; 32(1):231-43. PubMed ID: 24105925
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of transforming growth factor β1/Smad3 signaling decreases hypoxia-inducible factor-1α protein stability by inducing prolyl hydroxylase 2 expression in human periodontal ligament cells.
Watanabe T; Yasue A; Tanaka E
J Periodontol; 2013 Sep; 84(9):1346-52. PubMed ID: 23088526
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of prolyl hydroxylase 3 ameliorates cardiac dysfunction in diabetic cardiomyopathy.
Xia Y; Gong L; Liu H; Luo B; Li B; Li R; Li B; Lv M; Pan J; An F
Mol Cell Endocrinol; 2015 Mar; 403():21-9. PubMed ID: 25595486
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of hypoxia-inducible factor prolyl hydroxylase domain oxygen sensors: tricking the body into mounting orchestrated survival and repair responses.
Rabinowitz MH
J Med Chem; 2013 Dec; 56(23):9369-402. PubMed ID: 23977883
[TBL] [Abstract][Full Text] [Related]
15. Lactoferrin from bovine colostrum regulates prolyl hydroxylase 2 activity and prevents prion protein-mediated neuronal cell damage via cellular prion protein.
Park YG; Moon JH; Park SY
Neuroscience; 2014 Aug; 274():187-97. PubMed ID: 24875174
[TBL] [Abstract][Full Text] [Related]
16. HIF-prolyl hydroxylases and cardiovascular diseases.
Sen Banerjee S; Thirunavukkarasu M; Tipu Rishi M; Sanchez JA; Maulik N; Maulik G
Toxicol Mech Methods; 2012 Jun; 22(5):347-58. PubMed ID: 22424133
[TBL] [Abstract][Full Text] [Related]
17. Enzyme-Substrate Reporters for Evaluation of Substrate Specificity of HIF Prolyl Hydroxylase Isoforms.
Osipyants AI; Smirnova NA; Khristichenko AY; Hushpulian DM; Nikulin SV; Chubar TA; Zakhariants AA; Tishkov VI; Gazaryan IG; Poloznikov AA
Biochemistry (Mosc); 2017 Oct; 82(10):1207-1214. PubMed ID: 29037142
[TBL] [Abstract][Full Text] [Related]
18. Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors.
Henze AT; Riedel J; Diem T; Wenner J; Flamme I; Pouyseggur J; Plate KH; Acker T
Cancer Res; 2010 Jan; 70(1):357-66. PubMed ID: 20028863
[TBL] [Abstract][Full Text] [Related]
19. Effects of polynitrogen compounds on the activity of recombinant human HIF-1α prolyl hydroxylase 3 in E. coli.
Geng Z; Zhu J; Cao J; Geng J; Song X; Zhang Z; Bian N; Wang Z
J Inorg Biochem; 2011 Mar; 105(3):391-9. PubMed ID: 21421125
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes.
Taniguchi CM; Finger EC; Krieg AJ; Wu C; Diep AN; LaGory EL; Wei K; McGinnis LM; Yuan J; Kuo CJ; Giaccia AJ
Nat Med; 2013 Oct; 19(10):1325-30. PubMed ID: 24037093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
